000 01713 a2200397 4500
005 20250516080316.0
264 0 _c20130410
008 201304s 0 0 eng d
022 _a1744-7593
024 7 _a10.1517/17425247.2012.665365
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPalakurthi, Srinath
245 0 0 _aRecent trends in cancer drug resistance reversal strategies using nanoparticles.
_h[electronic resource]
260 _bExpert opinion on drug delivery
_cMar 2012
300 _a287-301 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aAptamers, Nucleotide
_xadministration & dosage
650 0 4 _aDrug Carriers
_xadministration & dosage
650 0 4 _aDrug Resistance
_xdrug effects
650 0 4 _aDrug Resistance, Multiple
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMicroRNAs
_xadministration & dosage
650 0 4 _aMolecular Targeted Therapy
_xinstrumentation
650 0 4 _aNanoparticles
_xadministration & dosage
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNeoplastic Stem Cells
_xdrug effects
650 0 4 _aRNA, Small Interfering
_xadministration & dosage
650 0 4 _aTumor Microenvironment
700 1 _aYellepeddi, Venkata Kashyap
700 1 _aVangara, Kiran Kumar
773 0 _tExpert opinion on drug delivery
_gvol. 9
_gno. 3
_gp. 287-301
856 4 0 _uhttps://doi.org/10.1517/17425247.2012.665365
_zAvailable from publisher's website
999 _c21550017
_d21550017